During the past decade, Revere Health conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Revere Health" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Siemens Healthcare" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Revere Health" are "Cardiovascular Disease" (2 trials) and "Myocardial Ischemia" (1 trials). Many other conditions were trialed in "Revere Health" in a lesser frequency.

Most popular intervention types in "Revere Health" are "Drug" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Stress cardiac magnetic resonance (CMR) perfusion imaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "Revere Health" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Revere Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Revere Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Revere Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".